# Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

> **NCT03772834** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **BEHAVIORAL:** Exercise Intervention
- **DRUG:** Methylphenidate
- **OTHER:** Placebo
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **OTHER:** Stretching

## Key facts

- **NCT ID:** NCT03772834
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-25
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03772834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03772834, "Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03772834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*